Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded an NIH funding line for 2016 and a new page revision tag v3.6.6, indicating updated attribution and document version. Removed the Plain Language Summary and the older revision tag v3.6.5.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, indicating a minor internal update. There are no visible changes to the study details or page behavior as a result of this revision.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision: v3.6.4 replaces v3.6.3 on the page, updating the document's version label.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2 in the study documents section.SummaryDifference0.0%

- Check81 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2. This indicates a newer build of the site rather than a modification to the study content.SummaryDifference0.0%

- Check96 days agoChange DetectedThe page now indicates that enrollment has ended and adds new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') along with a Revision: v3.6.0 label to reflect the latest update.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.